Загрузка...
Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting
INTRODUCTION: Chemotherapy-induced nausea and vomiting (CINV) represents a significant burden on patients and healthcare systems. Despite the introduction of serotonin antagonists, many patients still experience CINV, particularly delayed symptoms occurring more than 24 hours after chemotherapy. Apr...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2007
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3012554/ https://ncbi.nlm.nih.gov/pubmed/21221195 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|